Search
Pfizer Inc
PFEAdd to Watchlist
28.830USD
-0.620-2.11%
Close 11-12 16:00（ET）
164.32BMarket Cap
21.89P/E TTM
After-hours 19:44 (ET)28.880USD+0.015+0.05%
After-hours 19:44 (ET)Pfizer Inc (PFE) Stock Price Target & Forecast
Analyst Rating
Based on 30 analysts giving stock ratings to Pfizer Inc in the past month.
Hold
4 Strong Buy
6 Buy
17 Hold
2 Sell
1 Strong Sell
Target Price
29.029USD-4.89%
PFE Analyst Recommendation Trends
In the current month, PFE has received 6 Buy Ratings, 17 Hold Ratings, and 2 Sell Ratings. PFE average Analyst price target in the last month is 29.029.
2026-11
2026-10
2026-09
2026-08
2026-07
2026-06
2026-05
2026-04
4
4
5
5
5
4
5
4
6
6
6
7
7
9
7
7
17
17
19
18
17
16
16
17
1
1
1
1
1
1
1
1
2
2
1
1
2
2
2
2
30
30
32
32
32
32
31
31
PFE Analyst Rating for Peer Comparison
Updated: Nov 5, 2026Company name
Strong Buy
Buy
Hold
Sell
Strong Sell
Analysts
Biogen Inc
BIIB
8
16
12
1
0
37
Amgen Inc
AMGN
4
9
19
3
1
36
Vertex Pharmaceuticals Inc
VRTX
10
17
5
0
1
33
Eli Lilly and Co
LLY
10
19
3
1
0
33
Alnylam Pharmaceuticals Inc
ALNY
7
17
8
0
0
32
AbbVie Inc
ABBV
8
18
6
0
0
32
Neurocrine Biosciences Inc
NBIX
13
14
4
0
0
31
Merck & Co Inc
MRK
7
16
8
0
0
31
Bristol-Myers Squibb Co
BMY
5
6
18
1
0
30
Regeneron Pharmaceuticals Inc
REGN
6
15
9
0
0
30
Financial Forecasting
Based on analysts' estimates, PFE EPS is projected to reach 0.696 in FY2026Q4, following reported EPS of 0.569 in FY2026Q3. Track earnings expectations against reported figures to see how profitability is evolving.
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FY2026Q1
FY2026Q2
FY2026Q3
FY2026Q4
FY2027Q1
Forecast
0.72
0.68
0.73
0.70
0.69
Actual
0.47
-0.04
0.57
--
--
Surprise
-34.16%
-106.36%
-22.36%
--
--
FAQs
What is Pfizer Inc's expected revenue for the next quarter?
Pfizer Inc's expected revenue is 17.14B.
How have Pfizer IncPFE's recent earnings per share performed?
The market expectation was USD 0.57, while Pfizer IncPFE's earnings per share (EPS) for the previous quarter was USD -0.04. EPS for the next quarter is expected at USD 0.70.
What is the analyst rating for Pfizer Inc?
Based on the ratings of Pfizer Inc's stock from 30 analysts, most analysts support a signal_hold trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as signal_hold. Please note that this is not trading advice. You still need to conduct your own analysis.